BioCentury
ARTICLE | Financial News

CV Therapeutics attracts up to $120 million

August 8, 2000 7:00 AM UTC

CVTX received a commitment for up to $120 million over the next 28 months through a stock equity financing from Acqua Wellington. CVTX may at its discretion sell registered shares, at a small discount...